Eye on OOSS: Advocacy Matters, and It Works
-
By
-
Diane Blanck
-
Diane Blanck
-
May 1, 2026
-
6 min
By
Diane Blanck
Diane Blanck
May 1, 2026
At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.
by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS
May 1, 2026
The key is execution, understanding the clinical landscape, controlling device cost, engineering the intraoperative workflow, and scheduling/staffing with intention.
July 1, 2026
Moorfields and UCL launch dataset aiming to accelerate research into anterior segment conditions
July 16, 2026